课题基金 / 基金详情

Rates and Risk Factors for Hepatitis C Re-Infection or Late Relapse after Sustained Virologic Response to Treatment among HIV Co-Infected Canadians

Rates and Risk Factors for Hepatitis C Re-Infection or Late Relapse after Sustained Virologic Response to Treatment among HIV Co-Infected Canadians
合并感染艾滋病毒的加拿大人对治疗产生持续病毒学反应后丙型肝炎再次感染或晚期复发的比率和危险因素
批准号：
337208
负责人：
Rossi Carmine
金额：
$0.08万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-10-01 至 2016-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=337208&lang=en
关键词：
Co-Infection Cohort Epidemiology Hepatitis C Virus Hiv Ics Travel Awards Incidence Rates Injection Drug Use Risk Factors Virologic Response

项目摘要

项目成果

Rossi Carmine的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Due to shared routes of transmission, co-infection with the Hepatitis C virus (HCV) occurs in over 20% of the 70,000 Canadians living with HIV. In the last three years, highly effective, albeit costly, treatments to cure HCV have been administered to HCV-
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of chronic hepatitis C virus (HCV) direct-acting antiviral therapy on extrahepatic manifestations among HIV co-infected British Columbians engaged in clinical care
Real-world effectiveness of direct-acting antiviral therapy for chronic hepatitis C among HIV co-infected Canadians receiving clinical care
Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations
Injection Cocaine Use and Renal Function Decline among Hepatitis C-HIV Co-Infected Canadians Receiving Clinical Care
国内基金
海外基金
Case-Cohort数据的半参数逆回归估计和纵向数据分析
  • 批准号：
    11071137
  • 项目类别：
    面上项目
  • 资助金额：
    22.0万元
  • 批准年份：
    2010
  • 负责人：
    杨瑛
  • 依托单位：
    清华大学